Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimates of the global burden of Congenital Rubella Syndrome, 1996-2019
Emilia Vynnycky, Jennifer K. Knapp, Timos Papadopoulos, et al.
International Journal of Infectious Diseases (2023) Vol. 137, pp. 149-156
Open Access | Times Cited: 21

Showing 21 citing articles:

Progress Toward Rubella and Congenital Rubella Syndrome Elimination — Worldwide, 2012–2022
Alan C Ou, Laura Zimmerman, James P. Alexander, et al.
MMWR Morbidity and Mortality Weekly Report (2024) Vol. 73, Iss. 8, pp. 162-167
Open Access | Times Cited: 16
Accelerating Global Measles and Rubella Eradication—Saving Millions of Lives, Preventing Disability, and Averting the Next Pandemic
David N. Dürrheim, Jon Kim Andrus, Shahina Tabassum, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 699-699
Open Access | Times Cited: 5
Seroprevalence for Measles, Varicella, Mumps and Rubella in the Trainee Obstetric Population: A Survey in Southern Italy
Brunella Perfetto, Giovanna Paduano, Elena Grimaldi, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 335-335
Open Access | Times Cited: 4
Global Status Report for the Verification of Measles and Rubella Elimination, 2022
Patrick O’Connor, Balcha Masresha, Desirée Pastor, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 947-947
Open Access | Times Cited: 4
A World without Measles and Rubella: Addressing the Challenge of Vaccine Hesitancy
David Higgins, Sean T. O’Leary
Vaccines (2024) Vol. 12, Iss. 6, pp. 694-694
Open Access | Times Cited: 3
Evolution and Contribution of a Global Partnership against Measles and Rubella, 2001–2023
Peter Strebel, Mark Grabowsky, Edward Hoekstra, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 693-693
Open Access | Times Cited: 3
Pregnant women and measles: we need to be vigilant during outbreaks
Asma Khalil, Athina Samara, Colin Campbell, et al.
EClinicalMedicine (2024) Vol. 72, pp. 102594-102594
Open Access | Times Cited: 2
Congenital Rubella Syndrome Does Not Increase with Introduction of Rubella-Containing Vaccine
Kurt Frey
Vaccines (2024) Vol. 12, Iss. 7, pp. 811-811
Open Access | Times Cited: 2
The path to eradication of rubella
Susan E. Reef, Joseph P. Icenogle, Stanley A. Plotkin
Vaccine (2023) Vol. 41, Iss. 50, pp. 7525-7531
Closed Access | Times Cited: 6
Epidemiological Features of Infectious Diseases in Children and Adolescents: A Population-Based Observational Study in Shandong Province, China, 2013–2017
Wenjing Wang, Haitao Wang, Ke Song, et al.
Children (2024) Vol. 11, Iss. 3, pp. 309-309
Open Access | Times Cited: 1
A case of congenital rubella syndrome and epidemiology of related cases in China, 2014–2023
Xiaoying Gong, Canjie Zheng, Quanjun Fang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling
Masahiko Hachiya, Emilia Vynnycky, Yoshio Mori, et al.
International Journal of Infectious Diseases (2024) Vol. 144, pp. 107053-107053
Open Access | Times Cited: 1
Serosurveillance for Measles and Rubella
Allison M. Brady, Elina El-Badry, Eriko Padron-Regalado, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 816-816
Open Access | Times Cited: 1
An Application of an Initial Full Value of Vaccine Assessment Methodology to Measles-Rubella MAPs for Use in Low- and Middle-Income Countries
Melissa Ko, Collrane Frivold, Mercy Mvundura, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1075-1075
Open Access | Times Cited: 1
Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations
Darin Zehrung, Bruce L. Innis, Auliya A. Suwantika, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1258-1258
Open Access | Times Cited: 1
Syndromic Retinitis Pigmentosa
Jessica S. Karuntu, Hind Almushattat, Xuan‐Thanh‐An Nguyen, et al.
Progress in Retinal and Eye Research (2024), pp. 101324-101324
Open Access | Times Cited: 1
Invasive Prenatal Diagnostics: A Cornerstone of Perinatal Management
Aleksy Świetlicki, Paweł Gutaj, Rafał Iciek, et al.
Applied Sciences (2024) Vol. 14, Iss. 16, pp. 6915-6915
Open Access
Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June – 1 July 2024
Philipp Lambach, Sheetal Silal, Alyssa N. Sbarra, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126307-126307
Open Access
Global challenges and solutions to achieving and sustaining measles and rubella elimination
Natasha S. Crowcroft, Anna A. Minta, Sébastien Antoni, et al.
Revista Panamericana de Salud Pública (2024) Vol. 48, pp. 1-1
Open Access
Assessment of Simplified Surveillance for Congenital Rubella Syndrome in Sudan, 2014–2017
Omayma Abdalla, Nada Ahmed, Hasan Mukhtar, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1447-1447
Open Access
Decreases in Congenital Rubella Syndrome Reflect Concerted Efforts Toward Rubella and Measles Elimination
Gavin B. Grant, Laura Zimmerman
International Journal of Infectious Diseases (2023) Vol. 137, pp. 162-162
Open Access | Times Cited: 1
Page 1

Scroll to top